Logo image of BLDR

BUILDERS FIRSTSOURCE INC (BLDR) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BLDR - US12008R1077 - Common Stock

102.89 USD
-0.3 (-0.29%)
Last: 12/31/2025, 8:04:00 PM
103.01 USD
+0.12 (+0.12%)
After Hours: 12/31/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, BLDR scores 4 out of 10 in our fundamental rating. BLDR was compared to 42 industry peers in the Building Products industry. BLDR has only an average score on both its financial health and profitability. BLDR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BLDR had positive earnings in the past year.
BLDR had a positive operating cash flow in the past year.
BLDR had positive earnings in each of the past 5 years.
Each year in the past 5 years BLDR had a positive operating cash flow.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

BLDR has a Return On Assets of 5.20%. This is comparable to the rest of the industry: BLDR outperforms 50.00% of its industry peers.
Looking at the Return On Equity, with a value of 13.76%, BLDR is in line with its industry, outperforming 59.52% of the companies in the same industry.
BLDR has a Return On Invested Capital (8.34%) which is comparable to the rest of the industry.
BLDR had an Average Return On Invested Capital over the past 3 years of 22.36%. This is significantly above the industry average of 12.61%.
The last Return On Invested Capital (8.34%) for BLDR is well below the 3 year average (22.36%), which needs to be investigated, but indicates that BLDR had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.2%
ROE 13.76%
ROIC 8.34%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

BLDR's Profit Margin of 3.79% is on the low side compared to the rest of the industry. BLDR is outperformed by 61.90% of its industry peers.
In the last couple of years the Profit Margin of BLDR has grown nicely.
With a Operating Margin value of 6.57%, BLDR is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
BLDR's Operating Margin has improved in the last couple of years.
BLDR's Gross Margin of 30.97% is in line compared to the rest of the industry. BLDR outperforms 50.00% of its industry peers.
BLDR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.57%
PM (TTM) 3.79%
GM 30.97%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

BLDR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
BLDR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BLDR has less shares outstanding
BLDR has a worse debt/assets ratio than last year.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.80 indicates that BLDR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.80, BLDR perfoms like the industry average, outperforming 40.48% of the companies in the same industry.
The Debt to FCF ratio of BLDR is 4.35, which is a neutral value as it means it would take BLDR, 4.35 years of fcf income to pay off all of its debts.
BLDR's Debt to FCF ratio of 4.35 is in line compared to the rest of the industry. BLDR outperforms 54.76% of its industry peers.
BLDR has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.03, BLDR is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.35
Altman-Z 2.8
ROIC/WACC0.95
WACC8.77%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

BLDR has a Current Ratio of 1.79. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.79, BLDR is in line with its industry, outperforming 42.86% of the companies in the same industry.
A Quick Ratio of 1.15 indicates that BLDR should not have too much problems paying its short term obligations.
BLDR has a Quick ratio (1.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.15
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

BLDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.73%.
The Earnings Per Share has been growing by 40.71% on average over the past years. This is a very strong growth
Looking at the last year, BLDR shows a decrease in Revenue. The Revenue has decreased by -6.44% in the last year.
Measured over the past years, BLDR shows a quite strong growth in Revenue. The Revenue has been growing by 17.64% on average per year.
EPS 1Y (TTM)-36.73%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-38.76%
Revenue 1Y (TTM)-6.44%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-6.88%

3.2 Future

The Earnings Per Share is expected to decrease by -2.90% on average over the next years.
BLDR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.08% yearly.
EPS Next Y-37.6%
EPS Next 2Y-25.52%
EPS Next 3Y-10.39%
EPS Next 5Y-2.9%
Revenue Next Year-7.17%
Revenue Next 2Y-3.81%
Revenue Next 3Y-0.68%
Revenue Next 5Y1.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.73 indicates a correct valuation of BLDR.
Based on the Price/Earnings ratio, BLDR is valued cheaper than 80.95% of the companies in the same industry.
When comparing the Price/Earnings ratio of BLDR to the average of the S&P500 Index (26.51), we can say BLDR is valued rather cheaply.
A Price/Forward Earnings ratio of 16.09 indicates a correct valuation of BLDR.
Based on the Price/Forward Earnings ratio, BLDR is valued a bit cheaper than 64.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BLDR to the average of the S&P500 Index (23.13), we can say BLDR is valued slightly cheaper.
Industry RankSector Rank
PE 12.73
Fwd PE 16.09
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than BLDR, based on the Enterprise Value to EBITDA ratio.
88.10% of the companies in the same industry are more expensive than BLDR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.15
EV/EBITDA 9.69
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

BLDR has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as BLDR's earnings are expected to decrease with -10.39% in the coming years.
PEG (NY)N/A
PEG (5Y)0.31
EPS Next 2Y-25.52%
EPS Next 3Y-10.39%

0

5. Dividend

5.1 Amount

BLDR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (12/31/2025, 8:04:00 PM)

After market: 103.01 +0.12 (+0.12%)

102.89

-0.3 (-0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-18 2026-02-18/bmo
Inst Owners104.74%
Inst Owner Change4.67%
Ins Owners2.49%
Ins Owner Change0.09%
Market Cap11.38B
Revenue(TTM)15.65B
Net Income(TTM)593.96M
Analysts74
Price Target135.17 (31.37%)
Short Float %4.26%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.43%
Min EPS beat(2)2.38%
Max EPS beat(2)12.49%
EPS beat(4)4
Avg EPS beat(4)8.92%
Min EPS beat(4)2.38%
Max EPS beat(4)12.49%
EPS beat(8)8
Avg EPS beat(8)12.55%
EPS beat(12)12
Avg EPS beat(12)24.1%
EPS beat(16)16
Avg EPS beat(16)36.2%
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-5.53%
Min Revenue beat(4)-17.56%
Max Revenue beat(4)0.31%
Revenue beat(8)2
Avg Revenue beat(8)-3.83%
Revenue beat(12)5
Avg Revenue beat(12)-2.18%
Revenue beat(16)9
Avg Revenue beat(16)1.88%
PT rev (1m)-2.09%
PT rev (3m)-5.25%
EPS NQ rev (1m)-2.02%
EPS NQ rev (3m)6.88%
EPS NY rev (1m)0.66%
EPS NY rev (3m)3.26%
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)-2.78%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.19%
Valuation
Industry RankSector Rank
PE 12.73
Fwd PE 16.09
P/S 0.73
P/FCF 11.15
P/OCF 8.16
P/B 2.64
P/tB N/A
EV/EBITDA 9.69
EPS(TTM)8.08
EY7.85%
EPS(NY)6.4
Fwd EY6.22%
FCF(TTM)9.23
FCFY8.97%
OCF(TTM)12.61
OCFY12.26%
SpS141.55
BVpS39.03
TBVpS-7.92
PEG (NY)N/A
PEG (5Y)0.31
Graham Number84.24
Profitability
Industry RankSector Rank
ROA 5.2%
ROE 13.76%
ROCE 10.73%
ROIC 8.34%
ROICexc 8.6%
ROICexgc 19.5%
OM 6.57%
PM (TTM) 3.79%
GM 30.97%
FCFM 6.52%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
ROICexc(3y)22.6%
ROICexc(5y)21.09%
ROICexgc(3y)52.47%
ROICexgc(5y)46.44%
ROCE(3y)28.8%
ROCE(5y)26.39%
ROICexgc growth 3Y-14.33%
ROICexgc growth 5Y9.79%
ROICexc growth 3Y-13.16%
ROICexc growth 5Y2.57%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
F-Score5
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.35
Debt/EBITDA 2.76
Cap/Depr 64.9%
Cap/Sales 2.39%
Interest Coverage 4.4
Cash Conversion 86.87%
Profit Quality 171.79%
Current Ratio 1.79
Quick Ratio 1.15
Altman-Z 2.8
F-Score5
WACC8.77%
ROIC/WACC0.95
Cap/Depr(3y)73.83%
Cap/Depr(5y)71.85%
Cap/Sales(3y)2.2%
Cap/Sales(5y)1.81%
Profit Quality(3y)125.27%
Profit Quality(5y)102.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.73%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-38.76%
EPS Next Y-37.6%
EPS Next 2Y-25.52%
EPS Next 3Y-10.39%
EPS Next 5Y-2.9%
Revenue 1Y (TTM)-6.44%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-6.88%
Revenue Next Year-7.17%
Revenue Next 2Y-3.81%
Revenue Next 3Y-0.68%
Revenue Next 5Y1.08%
EBIT growth 1Y-42.25%
EBIT growth 3Y-12.79%
EBIT growth 5Y32.41%
EBIT Next Year2%
EBIT Next 3Y3.55%
EBIT Next 5Y5.19%
FCF growth 1Y-52.65%
FCF growth 3Y-0.52%
FCF growth 5Y30.71%
OCF growth 1Y-47.7%
OCF growth 3Y2.41%
OCF growth 5Y30.02%

BUILDERS FIRSTSOURCE INC / BLDR FAQ

Can you provide the ChartMill fundamental rating for BUILDERS FIRSTSOURCE INC?

ChartMill assigns a fundamental rating of 4 / 10 to BLDR.


What is the valuation status of BUILDERS FIRSTSOURCE INC (BLDR) stock?

ChartMill assigns a valuation rating of 6 / 10 to BUILDERS FIRSTSOURCE INC (BLDR). This can be considered as Fairly Valued.


Can you provide the profitability details for BUILDERS FIRSTSOURCE INC?

BUILDERS FIRSTSOURCE INC (BLDR) has a profitability rating of 6 / 10.


Can you provide the financial health for BLDR stock?

The financial health rating of BUILDERS FIRSTSOURCE INC (BLDR) is 4 / 10.


What is the earnings growth outlook for BUILDERS FIRSTSOURCE INC?

The Earnings per Share (EPS) of BUILDERS FIRSTSOURCE INC (BLDR) is expected to decline by -37.6% in the next year.